4.5 Article

The cardenolides strophanthidin, digoxigenin and dihydroouabain act as activators of the human RORγ/RORγT receptors

Journal

TOXICOLOGY LETTERS
Volume 295, Issue -, Pages 314-324

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2018.07.002

Keywords

RORgamma; RORC; Th17; Agonist; Cardenolides; Molecular docking

Categories

Funding

  1. National Science Centre Grant [2015/19/B/NZ7/03778]

Ask authors/readers for more resources

Two isoforms of a ligand-activated nuclear receptor, ROR gamma and ROR gamma T, have been implicated in various physiological functions, including energy metabolism, circadian rhythm and immune system development. Using a stably transfected reporter cell line, we screened two chemical libraries and identified three cardenolides (natural, plant-derived pesticides) as activators of ROR gamma-dependent transcription. These compounds increased G6PC and NPAS2 expression in HepG2 cells, accompanied by increased occupancy of RORy within the promoters of these genes. Further, strophanthidin, digoxigenin and dihydroouabain upregulated IL17A and IL17F expression and enhanced IL17 secretion in Th17 human lymphocytes. Molecular docking analyses of these compounds to the ROR gamma LBD showed favorable docking scores, suggesting that cardenolides may act as agonists of the receptor. Thus, our results provide new chemical structures for further development of ROR gamma-selective modulators with virtual therapeutic potential.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available